论文信息 - Response to the editorial: “the international society of hypertension guidelines 2020 – a new drug treatment recommendation in the wrong direction?” - 字舞流文

Response to the editorial: “the international society of hypertension guidelines 2020 – a new drug treatment recommendation in the wrong direction?”

The title of the recent editorial by Prof. Kjeldsen et al. [1] suggests that the latest guidelines of the International Society of Hypertension (ISH) [2] have introduced a drug treatment recommenda...

B. Williams | A. Schutte | N. Poulter | T. Unger

[1] S. Oparil,et al. The International Society of Hypertension Guidelines 2020 – a new drug treatment recommendation in the wrong direction? , 2020, Blood pressure.

[2] Dorairaj Prabhakaran,et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. , 2020, Hypertension.

[3] G. Lip,et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. , 2018, European heart journal.

[4] Jackson T. Wright,et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2018, Journal of the American College of Cardiology.

[5] G. Bakris,et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. , 2008, The New England journal of medicine.

[6] R. Collins,et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled tri , 2005, The Lancet.

[7] C. Reid,et al. A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly. , 2003, The New England journal of medicine.